2024 FDA Oncology Center of Excellence
Pediatric Advocacy Forum

October 15, 2024 (9:00 AM - 1:00 PM, ET)

Registration to attend in-person at:

FDA White Oak Building 31, Great Room

10903 New Hampshire Avenue

Silver Spring, Maryland 20993

Question Title

* 1. Name:

Question Title

* 2. Email:

Question Title

* 3. Organization:

Question Title

* 4. We understand that you may identify with more than one group listed. However, please select the group that you identify with the most.

Question Title

* 5. Are you affiliated with a particular Cancer Advocacy organization?

Yes (please specify)

Question Title

* 6. How did you hear about this event?

Question Title

* 7. What types of pediatric cancer are you most interested in?

Question Title

* 8. What are your goals in attending this forum?

Question Title

* 9. What topics are you most interested in discussing at this forum? (Please choose from 1 to 3 options)

FDA efforts to promote drug development for pediatric patients with cancer (e.g., stakeholder outreach and interactions, initiatives to facilitate equitable access to clinical trials, use of pediatric regulations, patient listening sessions)

Expedited programs to promote drug development (e.g., accelerated approval)

Dosage optimization and access to age-appropriate formulations (e.g., suspensions or minitablets)

Long-term safety concerns (e.g., effects on growth, development, and fertility)

Pediatric oncology trial considerations (e.g., role of proof-of-concept nonclinical studies, data sharing, randomized trial designs, external or hybrid controls)

Compassionate use access to investigational drugs

Recent FDA approvals of drugs to treat pediatric cancers

FDA role in clinical trial design and conduct

FDA decision-making process (e.g., review of marketing applications, regulatory requirements for approval)

Role of patient-reported outcomes in pediatric oncology drug development

Oncology drug shortages

Other (please specify)

You control the information you provide when you enter a response in an open field text box presented in this survey. Please take care not to include sensitive personally identifiable information (PII) or information of a personal nature about yourself or others. Aside from your name and email address for intended survey purposes, do not include names, contact information, full or partial Social Security number, dates of birth, employee number, medical information or any other sensitive or personal data.

FDA uses social media and third-party (non-FDA) websites to share information and to engage with the public. Please see FDA's Privacy Policy on the use of third-party websites and applications.

FDA is using SurveyMonkey, a third-party web service, to conduct this survey. Your response to survey questions may be accessible to SurveyMonkey. The SurveyMonkey privacy policy is available here: SurveyMonkey.com/Momentive's Privacy Policy.

2024 FDA Oncology Center of ExcellencePediatric Advocacy Forum

Question Title

* 1. Name:

Question Title

* 2. Email:

Question Title

* 3. Organization:

Question Title

* 4. We understand that you may identify with more than one group listed. However, please select the group that you identify with the most.

Question Title

* 5. Are you affiliated with a particular Cancer Advocacy organization?

Question Title

* 6. How did you hear about this event?

Question Title

* 7. What types of pediatric cancer are you most interested in?

Question Title

* 8. What are your goals in attending this forum?

Question Title

* 9. What topics are you most interested in discussing at this forum? (Please choose from 1 to 3 options)

2024 FDA Oncology Center of Excellence
Pediatric Advocacy Forum